Rapport Therapeutics, Inc.
RAPP
$38.08
$0.842.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 67.07% | 60.68% | 59.99% | -22.52% | 47.68% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.57% | 76.98% | 736.44% | 645.38% | 1.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 95.24% | 95.24% | -97.60% | -96.75% | 0.00% |
| Total Current Assets | 66.58% | 60.93% | 59.74% | -20.67% | 46.42% |
|
|
|||||
| Total Current Assets | 66.58% | 60.93% | 59.74% | -20.67% | 46.42% |
| Net Property, Plant & Equipment | 8.93% | 159.20% | 171.05% | 171.20% | 98.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 400.95% | 515.63% | 465.08% | 447.09% | -89.82% |
| Total Assets | 64.74% | 62.71% | 61.66% | -17.51% | 46.42% |
|
|
|||||
| Total Accounts Payable | 206.73% | 114.43% | 144.52% | 69.39% | 47.72% |
| Total Accrued Expenses | 39.85% | 99.21% | 70.08% | 25.87% | -19.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 159.42% | 273.81% | 244.72% | 150.21% | 46.94% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 90.74% | 117.28% | 101.66% | 46.74% | -5.08% |
|
|
|||||
| Total Current Liabilities | 90.74% | 117.28% | 101.66% | 46.74% | -5.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.81% | 1,081.19% | 908.59% | 804.57% | 426.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 60.85% | 192.22% | 195.22% | 138.63% | 45.01% |
|
|
|||||
| Common Stock & APIC | 67.64% | 67.41% | 67.17% | 3.50% | 1,414.77% |
| Retained Earnings | -72.58% | -90.09% | -94.16% | -102.42% | -117.02% |
| Treasury Stock & Other | -431.58% | 204.60% | -63.75% | 58.47% | 40.63% |
| Total Common Equity | 64.96% | 58.68% | 58.34% | -21.78% | 821.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 64.96% | 58.68% | 58.34% | -21.78% | 821.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 64.96% | 58.68% | 58.34% | -21.78% | 46.50% |
|
|
|||||